• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Johnson Jeh C.

    (Last) (First) (Middle)
    METLIFE, INC.
    200 PARK AVENUE

    (Street)
    NEW YORK NY 10166

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    METLIFE INC [ MET ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/19/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/19/2023 P(1) 17 A $51.69 2,526 D
    Common Stock 12/14/2023 A(2) 19 A $66.9 2,545 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This transaction was executed by an unaffiliated broker for an account of the reporting person. The broker did not discuss this transaction with the reporting person at the time the trades were made and the reporting person only recently became aware that such transaction had occurred.
    2. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
    Remarks:
    The reporting person's disclosure rounds deferred shares to the nearest whole number.
    /s/ Anna Nazarenko, Authorized Signer 12/18/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    SEC Filings

    See more
    • SEC Form 144 filed by MetLife Inc.

      144 - METLIFE INC (0001099219) (Subject)

      6/20/25 4:54:34 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form 144 filed by MetLife Inc.

      144 - METLIFE INC (0001099219) (Subject)

      6/20/25 4:43:46 PM ET
      $MET
      Life Insurance
      Finance
    • SEC Form 144 filed by MetLife Inc.

      144 - METLIFE INC (0001099219) (Subject)

      6/20/25 4:34:42 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hubbard Robert Glenn was granted 964 shares, increasing direct ownership by 0.97% to 100,489 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:37 PM ET
      $MET
      Life Insurance
      Finance
    • Director Johnson Jeh C. was granted 562 shares, increasing direct ownership by 9% to 6,789 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:17 PM ET
      $MET
      Life Insurance
      Finance
    • Director Morrison Denise M was granted 562 shares, increasing direct ownership by 2% to 32,817 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:06 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on MetLife with a new price target

      BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

      1/23/25 7:50:09 AM ET
      $MET
      Life Insurance
      Finance
    • TD Cowen initiated coverage on MetLife with a new price target

      TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

      10/9/24 7:52:22 AM ET
      $MET
      Life Insurance
      Finance
    • Barclays initiated coverage on MetLife with a new price target

      Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

      9/5/24 8:14:53 AM ET
      $MET
      Life Insurance
      Finance